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Abstract  16 
The light spectrum above 650 nm allows for good tissue penetration depths, far-red and near-17 
infrared fluorescent dyes are therefore popular fluorophores applied in (bio)medical diagnostics, 18 
including image-guided surgery. However, near-infrared fluorescent dyes often suffer from 19 
instability and limited brightness, two important features that, together with the labelling efficiency 20 
(e.g., non- one- or di-conjugated products) and serum-dye interactions are key elements that drive 21 
in vivo characteristics. Due to the fact that stability and brightness of far-red fluorophores are often 22 
superior over near-infrared dyes, interest in the use of dyes such as Cy5 is increasing. As there are 23 
clear indications that the influence of the chemical structure on the (photo)physical properties of a 24 
dye is dye-structure-dependent, the (photo)physical properties of ten structural variants of 25 
asymmetrical Cy5-(R1)R2-(R3)COOH (R representing the varied substituents) were extensively studied, 26 
While stacking in solution was not induced in most of the Cy5 far-red fluorophores, multimers and 27 
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stacking characteristics were observed in protein conjugates. And although all dye variants were 28 
shown to be stable towards photobleaching, clear differences in brightness and serum interactions 29 
were found. Combined, these findings indicate that the chemical substituents prominently influence 30 
the photophysical properties of Cy5 dyes, a feature that should be considered when using 31 
fluorescent dyes in future tracer development.   32 
 33 
1. Introduction 34 
Fluorescent dye-based guidance during surgical interventions is being recognised as an improvement 35 
in the accuracy of clinical care [1–3]. In clinical trials, fluorescence imaging has been used as a sole 36 
modality or in a bimodal/hybrid form, wherein it extends the field of nuclear medicine [4]. While 37 
fluorescence emissions across the light spectrum have been used for image guided surgery [2], 38 
emphasis lies on the use of dyes emitting in the far-red (650 nm < λem< 750 nm) or near-infrared 39 
(NIR) region (λem > 750 nm)[5]. This theoretical preference can be attributed to the enhanced 40 
penetration depths and limited auto-fluorescence in at these wavelengths.  41 
 Unfortunately, the dye chemistry, stability and/or photophysical properties of near-infrared 42 
dyes are limited compared to dyes emitting at lower wavelengths. For example, the most commonly 43 
applied near-infrared dye indocyanine green (ICG) is prone to stack/aggregate from aqueous 44 
solutions and has a low quantum yield (QF  = 0.3% in H2O)[6]. More experimental dyes such as IRdye 45 
800CW also have a low quantum yield (QF = 3.4% in H2O)[7] and have been shown to be chemically 46 
unstable with respect to endogenous nucleophiles [8]. These limitations have boosted the interest in 47 
far-red dyes. For instance, methylene blue (MB), a clinically applied dye with a weak far-red 48 
fluorescence emission (QF = 3% in H2O) has been applied in humans to image ureters [9], parathyroid 49 
glands [10], and bile ducts [11], despite the FDA warning against its use [12]. As an alternative, the 50 
Cy5 family provides relatively bright (~ 3·104 M-1·cm-1, QF ≈ 20 % in H2O )[13] far-red fluorophores and 51 
encompasses many structural variations. A prime example of a Cy5-based imaging agent in clinical 52 
use is found in GE-137 (now EM-137), a Cyanine 5 (Cy5)-labelled c-Met-targeting peptide that was 53 
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effectively used for identification of colorectal polyps in humans [14]. Furtermore, the Cy5-54 
containing nanoparticles 124I- cRGDY-PEG-C have been used to target metastatic melanoma [15].  55 
To convert Cy5-dyes into imaging agents of value for fluorescence-guided surgery, these 56 
dyes have to be conjugated to targeting vectors. When a targeting vector has multiple conjugation 57 
sites, e.g. a protein, labelling may not be straightforward. A ratio of one dye per targeting vector is 58 
generally aimed at, but the final product often consists of, e.g., a mixture of none-, one-, di-, and/or 59 
tri-dye conjugated imaging agents. In case multiple dyes are located on a single targeting vector, the 60 
occurrence of dye-stacking or Förster Resonance Energy Transfer (FRET) between the dyes can cause 61 
luminescence quenching, a feature that reduces the brightness of the imaging agent [8].  62 
 Conjugation of imaging labels, and especially an excess thereof, may also negatively 63 
influence the binding specificity and pharmacokinetics of a targeting vector. Dependent on the size 64 
of the targeting vector, the scale of these effects varies [16], being most prominent when relatively 65 
small peptides are used [14,17]. Nevertheless, this effect is also reported for larger proteins, e.g., 66 
mAb conjugates [18]. When dyes express an affinity for serum proteins such as human serum 67 
albumin, e.g., ICG and Cy5-(Ar)SO3-(Ar)SO3 [19–21], this may further effect the tracer 68 
pharmacokinetics. 69 
In order to determine the influence of the structure of a florescent dye on its utility as an 70 
imaging label, ten Cy5 analogues were synthesised and compared with the reference compound MB. 71 
By alternating the aromatic (R1 and R3) and alkyl substituents (R2), molecular variations on Cy5-72 
(R1)R2-(R3)COOH were systematically evaluated for their photophysical properties, chemical- and 73 
photo-stability, serum protein interaction, dye–dye stacking tendencies, and conjugation efficiency 74 
(Figure 1).  75 
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 76 
Figure 1. Overview of the subjects and fluorophore properties investigated and discussed throughout the 77 
article.  78 
 79 
2. Experimental 80 
2.1. Materials and reagents 81 
For the synthesis of the fluorophores (Compound 1-21), cLog P calculations, and information on the 82 
materials used, please refer to the Supporting information (SI). The electron density modelling is 83 
reported in Ref [22] 84 
 85 
2.2 Ubiquitin Labelling (compound 22–30) 86 
Stock solutions of the NHS-activated fluorophores (12–21, see SI) were prepared in DMSO and the 87 
percentage of activated dye was determined by HPLC (see also SI ‘NHS activation’). Subsequently, 88 
Ubiquitin (16 nmol) was dissolved in 500 µL of phosphate buffer (0.1 M, pH 8.4, 2.67 g HNa2PO4 + 89 
0.14 g H2NaPO4 in 200 µL H2O). Appropriate amounts of the fluorophore stock solution were added, 90 
ensuring that each sample contained 3 equivalents activated dye (50 nmol, 100 µM final 91 
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concentration) and that the DMSO content in the final solution was < 10%. The mixtures were 92 
shaken at room temperature for 6.5 h and the labelled Ubiquitin was washed with PBS by filtration 93 
over a 3K Amicon® filter subsequently. When the filtrate was no longer blue, the residue was 94 
collected in 100 µL PBS.  95 
Dye–Ubiquitin conjugates were analysed by mass spectrometry and absorption 96 
measurements using a NanoDrop. To determine the average labelling ratio, the dye concentration 97 
was calculated from absorption measurements in DMSO around 650 nm (Table 1) and the obtained 98 
values were then divided by the known protein concentration (0.16 mM). For compound 30 99 
significant precipitation was observed after the reaction, therefore the protein content in this 100 
sample also was determined by absorption (ε280 = 1490 M-1·cm-1, calculated from the amino acid 101 
sequence) [23]. Since Cy5 also shows absorbance at this wavelength, a correction was made by 102 
measuring the absorbance of free dye at this concentration and subtracting it from the absorbance 103 
value measure for the dye containing Ubiquitin. 104 
 105 
2.3 Photophysical properties 106 
2.3.1. Molar extinction coefficient (ε) of compound 1–11 107 
To obtain a 4 mM stock solution of MB (1), 3.2 mg Methylene blue hydrate (Fisher Scientific) was 108 
dissolved in 4 mM ethylene carbonate in DMSO-d6 (1500 µL) and the exact concentration was 109 
determined by NMR using ethylene carbonate as internal standard [8].  110 
To allow for absorption measurements, the 4 mM stock solutions of the dyes in DMSO-d6 (1-111 
11, for details, see SI) were diluted to 100 µM in DMSO, H2O or PBS. From the 100 µM concentration, 112 
50 µM and 5 µM concentrations were made from which further two-fold dilution in the same 113 
medium followed to obtain a final concentration range of 100, 50, 25, 12.5, 5, 2.5, 1.2, 0.6, and 0.3 114 
µM, respectively. Absorption spectra were measured using 1 mL disposable plastic cuvettes (l = 1 115 
cm; Brand, Germany) for concentrations ≤ 5 µM, quartz cuvettes (l = 0.1 cm; Hellma standard cell, 116 
Macro) for 12, 25, and 50 µM concentrations, and two glass microscopy slides held together with a 117 
6 
 
0.14 mm thick PET plastic spacer for the 100 µM concentration to keep the signal below 1.5 AU. 118 
Optical density was measured 10 minutes after preparation and the plotted absorbance was 119 
normalised for cuvette path length and concentration. The ε was then determined by applying a 120 
linear regression coefficient. 121 
   122 
2.3.2. Absorbance spectra of the labelled Ubiquitin (22–30) 123 
The Ubiquitin solutions collected after synthesis (for synthesis procedures see SI) were diluted 100 x 124 
in PBS and the absorbance spectra were measured using NanoDrop. Subsequently, the obtained 125 
spectra were normalised for dye concentration.  126 
 127 
2.3.3. Quantum yield and emission maximum determination of compound 1–11 and 22–30 128 
Fluorescence spectra were measured at λex = 606 nm for compounds 3–11 and the Ubiquitin 129 
conjugates 22–30, and λex = 620 nm for 1–2, using 1 cm disposable plastic 4.5 mL cuvettes (Kartell, 130 
Germany). 3 mL of 0.5 µM dye was prepared in PBS (1–11, 22–30) by first preparing 100 µM 131 
solutions in PBS from the DMSO-d6 dye stock (1–9 and MB solutions) or from dilutions of the 132 
Ubiquitin conjugates (22–30) (see SI for synthesis). To determine the quantum yield, the absorbance 133 
at λ = 606 (compounds 3–11 and 22–30) or λ = 620 nm (compound 1–2) of 0.5 µM and 0.25 µM were 134 
measured and correlated with the integrated fluorescent emission. The regression coefficient of the 135 
resulting plot for the unknown dyes was then compared to the regression coefficient of Cy5-136 
(SO3)COOH-(SO3)COOH (Figure 2), which has a known quantum yield (QF = 27%) [13]. 137 
 138 
 139 
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Figure 2. Chemical structure of the reference compound applied for the quantum yield determination; Cy5-140 
(SO3)COOH-(SO3)COOH.  141 
 142 
2.4 Stability 143 
2.4.1 Chemical stability of compound 1–11 towards glutathione 144 
Solutions of 0.25 mM dye (from DMSO-d6 NMR solutions) and 0.5 mM glutathione in 4-(2-145 
hydroxyethyl)-1-piperazine-ethanesulfonic acid buffer (HEPES, 0.1 M, pH 7.4) were freshly made. 146 
Prior to the addition of glutathione to the HEPES buffer, nitrogen was bubbled through the HEPES 147 
buffer to remove oxygen and reduce the rate of disulfide formation of glutathione. The solutions 148 
were immediately put into the sample manager (37 °C) of a Waters Acquity UPLC-MS system 149 
equipped with an Acquity UPLC photodiode array detector, an SQ Detector mass spectrometer and a 150 
Waters BEH C18 130 Å 1.7 μm (100 × 2.1 mm) column (flow rate: 0.5 mL/min). Analysis was 151 
performed every 30 minutes using a gradient of 0.05% TFA in H2O/0.04% TFA in CH3CN 95:5 to 0.05% 152 
TFA in H2O/0.04% TFA in CH3CN 5:95 in 5.44 minutes. The stability of the dyes was calculated relative 153 
to the integration of the chromatogram at t = 0 h. 154 
 155 
2.4.2 Optical stability of compound 1–11 156 
For the optical stability measurements, a prototype Karl Storz camera setup (KARL STORZ Endoskope 157 
GmbH & Co. KG, Tuttlingen, Germany) was applied. This camera setup included an IMAGE1 S H3-Z FI 158 
Three-Chip FULL HD camera head equipped with a 0o laparoscope in combination with an IMAGE 1 S 159 
CONNECT module, an IMAGE 1 S H3-LINK link module and a Cy5-modified D-light C light source (590-160 
680 nm emission). A standard eyepiece adaptor containing a filter that passes through light between 161 
640–720 nm (Cat no. 20100034; KARL STORZ Endoskope GmbH & Co. KG) was placed between the 162 
camera and the laparoscope to image the Cy5 fluorescence.  163 
From the DMSO-d6 dye stock solutions (see synthesis in SI) 100 µM solutions in PBS were 164 
prepared. Subsequently, from the 100 µM solutions, 3.0 mL of 1 µM solutions were prepared in 4.5 165 
8 
 
mL disposable cuvettes (Kartell, Germany). The cuvettes were placed in front of the prototype Karl 166 
Storz camera and illuminated at maximum intensity for 30 minutes. At 5-minute intervals the 167 
fluorescence was measured with λex = 602 nm. The reduction in fluorescence intensity was plotted 168 
and normalised relative to the fluorescence intensity obtained at t = 0 minutes.  169 
 170 
2.5 Serum protein interaction 171 
Serum protein binding was assayed using the single-use Rapid Equilibrium Dialysis (RED) plate kit 172 
with an 8 kD MWCO (Pierce, Thermo Scientific). Serum (300 µL, fetal bovine serum, heat inactivated) 173 
was placed into the dialysis chamber and phosphate buffer (500 µL, 100 mM phosphate and 150 mM 174 
NaCl, pH = 7.2) was placed into the reservoir chamber. The dyes were added from a DMSO stock 175 
(100 µM, 3 µL) to the dialysis chamber (n = 2) and in duplicate samples (n = 2) to the reservoir 176 
chamber. The plate was subsequently closed using sealing tape and incubated at room temperature 177 
on a rocking shaker for 18 h, after which 100 µL aliquots were withdrawn from both chambers for 178 
each dye. 100 µL phosphate buffer was then added to the aliquots containing serum, and 100 µL 179 
serum was added to the aliquots containing phosphate buffer. All aliquots were transferred to a 180 
white 96 well plate (Greiner Lumitrac 600) and fluorescence was quantified at λex = 620 nm using a 181 
PerkinElmer LS 55 fluorometer (equipped with a red-sensitive detector and a plate-reader 182 
attachment). Serum protein binding percentages were calculated using the manufacturer’s protocol 183 
(eq. 1): 184 
 %𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 = �100 − [𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏𝑏 𝑐𝑐ℎ𝑎𝑎𝑎𝑎𝑏𝑏𝑏𝑏𝑏𝑏][𝑠𝑠𝑏𝑏𝑏𝑏𝑏𝑏𝑎𝑎 𝑐𝑐ℎ𝑎𝑎𝑎𝑎𝑏𝑏𝑏𝑏𝑏𝑏] � ∙ 100 eq. 1 
 185 
2.6 Stacking behaviour of compound 1–11 in different solvents 186 
To determine the stacking behaviour of the dyes (1–11) in DMSO, H2O or PBS, the same dilutions and 187 
absorbance measurements were performed as described for measuring the molar extinction 188 
coefficient (chapter 2.3.1). For a more detailed description please refer to Ref [22]. 189 
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3. Results and Discussion 190 
3.1 Chemical properties 191 
The number of charges, and calculated Log P (cLog P) values of the investigated fluorophores are 192 
given in Figure 3. Overall, the calculated net charge decreased with increasing number of sulfonate 193 
moieties on the aromatic ring, which also resulted in decreasing cLog P values. The highest cLog P 194 
value was, as expected, calculated for compound 2 due to the presence of additional benzene rings. 195 
The lowest cLog P value was found for compound 11, as a result of the high total number of charges 196 
(5). The cLog P value of MB (1) was most similar to the cLog P value calculated for compound 6.  197 
 198 
 199 
Figure 3. The cLog P values of the compounds 1–11. In the compound structures the positively charged groups 200 
are indicated in blue and negatively charged groups are indicated in red. 201 
 202 
3.2 Photophysical properties 203 
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The molar extinction coefficient (ε) was calculated via the regression coefficient between the 204 
concentration and the absorbance determined from a linear concentration range between 0.3–5 µM 205 
in DMSO, H2O, and PBS. In DMSO, except for compounds 2, 4 (ε ≈ 185.000 M-1cm-1) and MB (1, ε = 206 
84.000 M-1cm-1), all dyes had ε > 200.000 M-1cm-1. The ε determined for MB in DMSO was in line with 207 
the literature, which reports values between 70.000 and 95.000 M-1cm-1 [24,25]. For compounds 3–8 208 
the ε decreased with about 25% when changing the solvent from DMSO to H2O or PBS. A more 209 
substantial decrease (37%) was observed for the more lipophilic compound 2. Remarkably, for the 210 
more soluble compounds with two aromatic sulfonates (9–11) the change in solvent resulted in a 211 
10% increase in the ε and gave extinction coefficients of 242.000, 220.000 and 231.000 M-1cm-1 in 212 
PBS respectively (Table 1). 213 
The absorption/emission maxima of the Cy5 fluorophores (2–11) observed in DMSO had 214 
Stokes shifts of about 20 nm (Table 1) while MB (1) had a Stokes shift of 16 nm. Changing the solvent 215 
from DMSO towards H2O or PBS caused a hypsochromic shift in the absorption/emission maximum 216 
of 10 nm for 2–11 and only a minor shift (5 nm) for MB. Comparison of the absorption/emission 217 
maxima (Table 1) with the structure of the dyes (Figure 3), revealed that all compounds with a 218 
sulfonate on both aromatic rings (9–11) displayed a slight bathochromic shift of around 5 nm in their 219 
maxima. This bathochromic shift has also been reported for other Cy5-fluorophores [26]. This effect 220 
was, however, not observed when no or just one aromatic sulfonate was present at this location 221 
(e.g., 9 vs 3 and 6, Table 1). 222 
In practice, the environment of the fluorophores will be aqueous, hence the quantum yields 223 
measurements were performed in PBS and related to that of Cy5-(SO3)COOH-(SO3)COOH (ΦF = 27%) 224 
[13]. In line with the above-presented molar extinction coefficients, the quantum yields of 225 
compounds 9, 10, and 11 were also the highest (23%) from the series; the other Cy5-dye derivatives 226 
displayed quantum yields around 13% or lower (Table 1). In contrast, MB yielded a quantum yield of 227 
merely 3%. It is interesting to note that the quantum yields did not alter significantly upon changing 228 
the alkyl substituent (e.g., 3 vs 4 vs 5, Table 1), or changing the number of aromatic sulfonates from 229 
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0 to 1 (e.g., 3 vs 6). As Fisher et al. suggested [27], a clear trend between the structure of dyes and 230 
the quantum yield seems to be missing. 231 
 232 
Table 1. Photophysical properties of compound 1–11, including the quantum yields of 22–30. 233 
Dye ε in DMSO a 
(M-1·cm-1) 
ε in water a 
(M-1·cm-1) 
ε in PBS a 
(M-1·cm-1) 
λex/λem in 
DMSO 
(Stokes shift; 
nm) 
λex/λem in 
H2O and PBS 
(Stokes shift; 
nm) 
ΦF in PBS b 
Non-
conjugated 
ΦF in PBS b 
Conjugated 
(22–30) 
MB
(1) 
  84 · 103   77 · 103   71 · 103 670/686 (16) 665/679 (14) 3% n.a. c 
2 181 · 103 113 · 103 112 · 103 688/710 (22) 678/695 (17) 10% n.a. c 
3 200 · 103 199 · 103 203 · 103 655/671 (16) 643/659 (16) 14% 5% 
4 188 · 103 176 · 103 174 · 103 647/667 (20) 640/656 (16) 13% 10% 
5 218 · 103 193 · 103 193 · 103 658/677 (19) 638/658 (20) 13% 12% 
6 228 · 103 206 · 103 206 · 103 655/675 (20)  643/660 (17) 13% 9% 
7 238 · 103 176 · 103 212 · 103 653/672 (19) 642/658 (16) 13% 3% 
8 200 · 103 146 · 103 149 · 103 647/673 (26) 637/657 (20) 9% 14% 
9 219 · 103 245 · 103 242 · 103 660/679 (19) 648/664 (16) 22% 21% 
10 204 · 103 233 · 103 220 · 103 658/677 (19) 646/662 (16) 23% 14% 
11 209.0 · 103 223 · 103 231 · 103 659/677 (18) 645/661 (16) 23% 20% 
a) Fresh dilutions from the DMSO stock were made and measured within 2 hours 234 
b) Relative quantum yield, compared to Cy5-(SO3)COOH-(SO3)COOH (ΦF = 27%)[13] 235 
c) Labelling was not successful 236 
With ε for molar extinction coefficient, λex/λem for excitation/emission wavelength, ΦF for quantum yield and 237 
n.a. for not applicable.  238 
 239 
Although emphasis is generally placed on the molar extinction coefficient or quantum yield 240 
individually, the combination of both properties, i.e., the brightness (quantum yield x molar 241 
extinction coefficient)[28], often gives more insight in the optical capability of the fluorophores. This 242 
difference also becomes apparent from Figure 4, where all 11 fluorophores are imaged by a 243 
prototype Karl Storz camera setup (λex = 590–680 nm, data collection between 640–750 nm). For 244 
proper in vivo visualisation, a signal-to-background ratio (e.g., tumour to muscle) of at least 2 is 245 
required [29]. On the basis of the signal-to-background ratio calculated from Figure 4, one can 246 
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deduct that a brightness > 1·104 M-1·cm-1 is required to achieve a signal to background ration > 2. 247 
With a brightness of 3·103 M-1·cm-1 and a signal to background ration of 1.6, MB fluorescence was 248 
considered too weak to be detected accurately (Figure 4B). Since fluorescence imaging of MB has 249 
already been used in clinical trials, this finding underlines the medical potential of the relatively 250 
bright Cy5 dyes [30]. 251 
 252 
 253 
 254 
Figure 4. Brightness of the fluorophores in PBS (1 µM) measured by Storz camera (A) or calculated (B). From 255 
the image (A) the corresponding signal to background ratios were calculated (B). Overall, the fluorophores 256 
with two aromatic sulfonates (9–11) emit the brightest fluorescence, while MB is hardly visible at all (signal to 257 
background ratio < 2).  258 
 259 
Figure 4 indicates that the fluorophores with two aromatic sulfonates (9–11) possess the 260 
best optical properties. It is known that electron-withdrawing groups, e.g., sulfonates, substituted on 261 
the aromatic ring, increase the brightness of such fluorophores [31]. Interestingly, despite their 262 
match in brightness, Spartan calculations revealed differences in the theoretical electron densities 263 
(Figure 2 in Ref [22], please refer to Ref [22] for further details). Hence, in line with the report by 264 
Levitus et al.,[32] the positive effect of aromatic sulfonates on the optical properties might not solely 265 
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lie in the electrostatic withdrawing capacity. According to the combined data in Table 1 and Figure 2 266 
in Ref [22], the concept of reinforced conformal stability seems to offer a more probable explanation 267 
for the sulfonate induced increase in fluorescence brightness; cis-trans photoisomerisations of the 268 
central methine bridge influences the fluorescence brightness [33]. In the ground state, the main 269 
conformation of the Cy5 dyes is the  trans-conformation [32]. However, when excited, the methine 270 
bridge can rotate around its C–C bonds, twisting towards the cis-conformation [32,34]. In the cis-271 
conformation, the most probable route towards the ground state is via non-luminescent internal 272 
conversion due to the high overlap in the vibronic wave functions (Frank-Condon factor) [26]. It has 273 
been speculated that sulfonation of the aromatic rings increases the stability of the trans-274 
conformation, thereby reducing the rate of cis-trans photoisomerisation [32,34] and increasing the 275 
fluorescence brightness.  276 
 277 
3.3 Stability of the fluorophores 278 
As the fluorophores 2–11 were synthesised with a future use in image-guided surgery in mind, their 279 
optical stability was tested by exposure to a light source of a dedicated laparoscopic fluorescence 280 
camera (λex = 590–680 nm). With the exclusion of ambient light, fluorophore solutions of 1 µM in PBS 281 
were irradiated for a duration of 30 minutes, with an assessment of their fluorescence intensity at 5-282 
minute intervals. For most compounds, more than 90% of fluorescent signal remained after 30 283 
minutes, indicating good optical stability (Figure 5A). Only compound 2 showed 30% photobleaching. 284 
Although subtle, it is interesting to note that the fluorophores without sulfonates on the aromatic 285 
rings portrayed a slightly lower photostability (3–5)(~ 88% remaining fluorescence intensity) 286 
compared to the dyes with a sulfonated side chain (6–11)(95% remaining fluorescence intensity). 287 
This indicates that the substitution of sulfonates on the aromatic rings positively affects the optical 288 
stability of the fluorophores.  289 
 Earlier studies have underlined that it is also important that the dyes are chemically stable in 290 
an in vivo environment [8,35]. To evaluate the chemical stability of the dyes towards endogenous 291 
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nucleophiles, they were incubated for up to 6 hours at 37 °C in a model buffer containing 0.5 mM 292 
glutathione [8,36]. UPLC-MS was used to discriminate if any adducts were formed by reaction with 293 
the respective thiol. As apparent from Figure 5B, all fluorophores remained stable and fluorescent at 294 
the given conditions. This finding excludes the formation of unwanted products during in vivo 295 
administration, as was previously reported for the NIR dyes ZW800-1 and IRdye 800-CW [8]. 296 
 297 
 298 
Figure 5. Optical and chemical stability of the fluorophores and their tendency to interact with serum proteins. 299 
A) Optical stability; the dyes were illuminated using the light source of a prototype Karl Storz camera setup (λex 300 
= 590–680 nm). Reduction in fluorescence was measured up to 30 min with 5-minute intervals. In the legend 301 
the dyes are given in order of decreasing stability (arrow). B) Chemical stability of the eleven dyes in 0.5 mM 302 
glutathione in HEPES (pH 7.4) at 37 °C as assayed overtime by UPLC-MS. C) Percentage of fluorophore bound 303 
to serum proteins after 18 h of dialysis with serum versus PBS. The fluorophores are grouped in colour by their 304 
alkyl substituents and within each group the dye with non-, one-, and two sulfonates on the aromatic ring are 305 
given from left to right.  306 
 307 
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3.4 Serum protein interaction 308 
Next to the stability of the fluorophores towards endogenous nucleophiles, the tendency of the dyes 309 
to non-covalently bind to serum proteins was also evaluated. Equilibrium dialysis against serum (18 310 
h) revealed clear differences between the dyes (Figure 5C). Increasing the number of sulfonates on 311 
the aromatic ring induced an approximate 50% decrease in serum protein binding following each 312 
sulfonate introduced. Introducing a sulfonate on the side chain reduced the albumin interaction with 313 
about 30% compared to the neutral (Me-) substituted dyes. The quaternary-amine substituents 314 
reduced this even further. When these findings were related to the cLog P values, it appeared that 315 
there is a threshold value at cLog P = 0.8. For dyes portraying a cLog P above this value, i.e. lipophilic 316 
dyes, a serum protein binding tendency of > 50% was observed (compound 2, 3 and 4). When the 317 
cLog P value drops below 0.8, the influence of the lipophilicity seems to become less substantial and 318 
the number of charges on the compounds started to play a role, with the lowest percentage of 319 
binding found for compound 9 and 11 (< 10%, five total charges). Overall, both the aromatic 320 
substituents and alkyl substituents play a prominent role in the interaction with serum proteins. 321 
 322 
3.5 Stacking behaviour 323 
Previously we found that the degree of dye stacking observed in the reaction mixture was 324 
predictive for the amount of stacking of the dyes on the obtained conjugation products [8]. In 325 
general, the presence of multiple (stacked) dyes on the final product reduces the brightness and 326 
homogeneity of the sample. Therefore, the stacking-based aggregation rates of the eleven 327 
compounds investigated were determined in DMSO, PBS and H2O at concentrations ranging from 0.3 328 
to 100 µM. Compounds 3–11 did not aggregate in these solvents (Figure 6, for further details see Ref 329 
[22]), while MB and compound 2 did demonstrate distinct stacking in the aqueous media (Figure 6). 330 
Compound 2 showed aggregation at concentrations higher than 2.5 µM in PBS and H2O. A 331 
comparable aggregation tendency was reported earlier for ICG [8]. Based on this, the observed 332 
stacking at > 2.5 µM concentration in aqueous medium seems to be induced by the presence of the 333 
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two additional aromatic rings. MB showed an even stronger dimeric stacking tendency than 334 
compound 2, while the concentration dependency of this effect was comparable to that of 335 
compound 2 (Figure 6)[24]. 336 
 337 
Figure 6. The stacking concentration dependency of MB and compound 2, and 9 measured in DMSO, PBS and 338 
H2O at concentrations ranging from 0.3 to 100 µM. Compound 9 is shown as model for compound 3–11 as 339 
they were all comparable. For detailed visualisation of each compound separately please refer to Ref [22].  340 
 341 
3.5 Conjugation 342 
To investigate if the structure variations in the fluorophores have an influence on their conjugation 343 
characteristics, compounds 2–11 were activated (yielding compound 12–21, see SI) and conjugated 344 
to the reference protein Ubiquitin. This small (~ 8.5 kDa) [37], well-known regulatory protein is 345 
present in almost every eukaryotic cell and contains 7 lysine residues of which 6 are solvent-exposed 346 
(Figure 7A)(evaluated from the PDB structure 5DK8). The low molecular weight of Ubiquitin makes it 347 
possible to study the labelling process via mass spectrometry (MS), which helps provide insight into 348 
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the homogeneity of the products obtained within a single sample. Relating these findings to the 349 
absorbance profiles of the same products allowed for the determination of relative labelling ratios.  350 
The labelling with the fluorophore 2 was unsuccessful due to its low solubility at the 351 
required concentrations (100 µM). Thus, the conjugation reactions yielded nine Ubiquitin constructs 352 
(22–30). While previously no stacking was observed at the concentrations used in the reaction 353 
mixture (Figure 6), absorption spectra of the conjugation products 22, 23, 25, 26, and 29 revealed 354 
stacking (Figure 7B). The prescence of sulfonate groups on the aromatic ring decreased the stacking 355 
as did the precence of a quatenary amine on the side chain. When measured in DMSO, these 356 
stacking interactions were no longer present due to increased solvation of the dyes (Figure S2) and 357 
the dye loading rates could be accurately determined (Figure 7B; LR)[8]. The calculated loading rates 358 
were found to be comparable (around 1) with exception of compounds 25 (1.7) and 29 (1.6). 359 
However, except for being the only two dyes with a -2 net charge (Figure 3) there is no clear 360 
indication why these loading rates were higher than the others. 361 
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Figure 7. A) The Cy5 dyes conjugated to Ubiquitin. Within the structure of Ubiquitin the surface-exposed lysine 363 
groups and the N-terminus are indicated in yellow as probable binding sides for the fluorophores. The image 364 
was constructed from the PDB structure 5DK8. B) Absorption spectra of the dyes conjugated to Ubiquitin (22–365 
30) measured in PBS, including the dye loading rates (LR). The fluorophores on construct 22, 23, 25, 26, and 29 366 
are stacking as is indicated by the increase of the right shoulder peak. The spectra are normalised on dye 367 
concentration to underline the differences in the shape of the absorbances. C) Mass spectra of the conjugated 368 
Cy5–Ubiquitin compounds. The mass signals of M2+ are shown as these were the most intense, with m/z =  369 
4278 non-conjugated Ubiquitin, m/z ≈ 4500 mono-conjugated Ubiquitin and m/z ≈ 4800 di-conjugated 370 
Ubiquitin. 371 
 372 
When looking at the mass spectra of the conjugated Cy5-Ubiquitin compounds (22–30) it 373 
becomes evident that the samples are heterogeneously labelled and that this effect differs between 374 
dyes (Figure 7C). For the dyes with the sulfonated side chain (22, 25, 28), only the fluorophore with 375 
two aromatic sulfonates (28) labelled homogenously. For the dyes containing the methyl side chain 376 
(23, 26, 29) however, lower number of sulfonates on the aromatic rings resulted in a more 377 
homogenously labelled Ubiquitin (23). MS analysis of the compounds with a quaternary amine on 378 
the side chain (24, 27, 30) was more complex. The low ionisation of the mono or di-conjugated 379 
Ubiquitin resulted in a discrepancy between the information obtained by MS and what was 380 
calculated from the absorbance spectra. However, it can be concluded that also here the labelling 381 
was heterogeneous as multiple peaks were visible. Combining the absorbance and MS data, we 382 
demonstrated that while absorption spectra clearly indicate that the Cy5 dyes undergo a significant 383 
degree of stacking (in PBS Figure 7B, not in DMSO; Figure S2), the same samples only displayed a 384 
limited amount of di-conjugated Ubiquitin products (Figure 7C). Furthermore, no stacking was 385 
observed for the free form of these compounds at the same concentration (Figure 4, Figure 3 in Ref 386 
[22]). This suggests that the stacking observed is not the traditional dye–dye stacking, but comes 387 
from stacking interactions with, e.g. tyrosine, tryptophan, or phenylalanine amino acids within the 388 
protein. According to the crystal structure of Ubiquitin, there is at least one phenylalanine spatially 389 
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nearby every solvent-exposed Lysine (determined from the PDB structure 5DK8). The stacking 390 
interaction with the surrounding amino-acids is also be noted by the quantum yield (Table 1). After 391 
conjugation to the protein, the quantum yield of most compounds decreased, and the degree of 392 
reduction correlated with the observed amount of stacking. Indeed, also the diminishing quantum 393 
yield did not depend on whether the Ubiquitin is homogeneously labelled (one peak on the MS 394 
data), thus underlining the fact that the observed stacking occurs between the dye and neighbouring 395 
amino acids.     396 
When the investigated dyes were compared in a biodistribution study with RGD it was found 397 
that compound 7 yielded superior in vivo properties [17]. Based on the chemical characteristics 398 
investigated herein however, compound 7 did not stand out, pointing out that chemical 399 
characteristics are only one aspect in the development of efficient fluorescent tracers for in vivo use. 400 
In the end, the Cy5 dye becomes but a component of a larger molecular structure, of which the 401 
overall characteristics drive the targeting behaviour and biodistribution [17]. Given the apparent 402 
balance that has to be obtained between the chemical characteristics of the dye and a targeting 403 
vector, it seems to be inevitable that labelling of an individual targeting vector goes hand-in-hand 404 
with screening of different Cy5-dyes structures, e.g. as presented in Figure 3. Nevertheless, in 405 
fluorescent tracer design we would like to suggest that only dyes are used that are: (photo-406 
)chemically stable, bright enough to obtain a signal-to-background ratio of at least 2 with the 407 
cameras intended for clinical use, show no stacking in solution, and ideally label proteins 408 
homogeneously.  409 
 410 
4. Conclusion 411 
In this study, the characteristic chemical and photophysical properties of ten systematically altered 412 
Cy5 derivatives and their Ubiquitin conjugates were methodically analysed. Next to these structure–413 
activity relationships, the compatibility of the dyes with a clinical-grade fluorescence laparoscope 414 
was also presented. Overall, the influence of the aromatic- and alkyl substituents on the chemical- 415 
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and photophysical properties of the ten Cy5 dyes has been documented more clearly, providing a 416 
solid basis for future tracer developments.  417 
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